Anti-Tumour Necrosis Factor-α Therapy for Rheumatoid and Other Inflammatory Arthropathies

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Drugs & Aging

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00002512-200623110-00001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.

  2006cited by this paper
• Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.

  2006cited by this paper
• Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

  2006cited by this paper
• The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.

  2006cited by this paper
• Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial.

  2005cited by this paper
• Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001).

  2005cited by this paper
• Nouveaux enjeux de l'ostéoporose pour le rhumatologue

  2005cited by this paper
• Infections in patients with rheumatoid arthritis treated with biologic agents.

  2005cited by this paper
• Does age bias the aggressive treatment of elderly patients with rheumatoid arthritis?

  2005cited by this paper
• Survival and safety of treatment with infliximab in the elderly population.

  2005cited by this paper
• Severe pyogenic infections in patients taking infliximab: a regional cohort study.

  2005cited by this paper
• Long term safety of etanercept in elderly subjects with rheumatic diseases

  2005cited by this paper
• Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.

  2004cited by this paper
• Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.

  2004cited by this paper
• Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

  2004cited by this paper
• Observational cohort studies and well controlled clinical trials--we need them both!

  2004cited by this paper
• Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.

  2003cited by this paper
• Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study

  2003cited by this paper
• Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy.

  2003cited by this paper
• Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis.

  2003cited by this paper
• Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.

  2003cited by this paper
• Infections and biological therapy in rheumatoid arthritis.

  2003cited by this paper
• Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.

  2003cited by this paper
• Infections and anti–tumor necrosis factor α therapy

  2003cited by this paper
• Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial.

  2003cited by this paper
• Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

  2003cited by this paper
• Anti-tumour necrosis factor (TNF)-α therapy in undifferentiated spondyloarthropathy

  2002cited by this paper
• Manual jobs increase the risk of patients with ankylosing spondylitis withdrawing from the labour force, also when adjusted for job related withdrawal in the general population

  2002cited by this paper
• What are the risks of biologic therapy in rheumatoid arthritis? An update on safety.

  2002cited by this paper
• Recommendations about the prevention and management of tuberculosis in patients taking infliximab.

  2002cited by this paper
• Guidelines for the management of rheumatoid arthritis: 2002 Update.

  2002cited by this paper
• Adverse reactions to TNF-α inhibitors in rheumatoid arthritis

  2002cited by this paper
• Guidelines for the management of rheumatoid arthritis: 2002 update.

  2002cited by this paper
• Predictors of infection in rheumatoid arthritis.

  2002cited by this paper
• Infliximab in the treatment of active and severe ankylosing spondylitis.

  2002cited by this paper
• “Stepping-up” from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate

  2001cited by this paper
• Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

  2000cited by this paper
• A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.

  2000cited by this paper
• Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFα treatment

  1999cited by this paper
• The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985.

  1999cited by this paper
• A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.

  1999cited by this paper
• Etanercept Therapy in Rheumatoid Arthritis

  1999cited by this paper

• Rheumatoid Arthritis

  2019cites this paper
• Investigation into the Impact of Aging on Serious Adverse Events Associated with Antirheumatic Agents Using the Japanese Adverse Drug Event Report Database

  2018cites this paper
• Performance of the classification criteria in patients with late-onset axial spondyloarthritis

  2018cites this paper
• Common rheumatologic diseases in the elderly

  2016cites this paper
• Diagnosis and Management of Late-Onset Spondyloarthritis: Implications of Treat-to-Target Recommendations

  2015cites this paper
• Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis.

  2015cites this paper
• Artritis psoriásica: Contribuciones al conocimiento de su patogenia, de sus comorbilidades y al perfil de seguridad de su tratamiento

  2014cites this paper
• FOOD VALUES OF TWO ENDEMIC WILD ALMOND SPECIES FROM IRAN

  2014cites this paper
• An Eco‐Friendly Enantioselective Access to (R)‐Naringenin as Inhibitor of Proinflammatory Cytokine Release

  2013cites this paper
• Systematic review and analysis of evidences on clinical efficacy and cost-effectiveness of biological drugs for the treatment of Ankylosing Spondylitis

  2013cites this paper
• Chiral Flavanones from Amygdalus lycioides Spach: Structural Elucidation and Identification of TNFalpha Inhibitors by Bioactivity-guided Fractionation

  2012cites this paper
• [Systematic review: safety and efficacy of anti-TNF in elderly patients].

  2011cites this paper
• TNF alpha antagonist therapy and safety monitoring.

  2011cites this paper
• Revisión sistemática: eficacia y seguridad del tratamiento anti-TNF en pacientes ancianos

  2011cites this paper
• Late-Onset Ankylosing Spondylitis and Spondylarthritis

  2010cites this paper
• Preliminary study on TNFα-blocker activity of Amygdalus lycioides spach extracts.

  2010cites this paper
• The older rheumatoid arthritis patients: who are they and how should they be treated?

  2010cites this paper
• Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis

  2010cites this paper
• Patterns of Biologic Agent Use in Older Males with Inflammatory Diseases

  2009cites this paper
• Elderly Onset Rheumatoid Arthritis

  2009cites this paper
• [Therapeutic approach for systemic diseases in the elderly. Horton disease and rhizomelic pseudopolyarthritis].

  2008cites this paper
• Etanercept Treatment in Myasthenia Gravis

  2008cites this paper
• Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.

  2007cites this paper
• 37 - Drugs that act on the immune system: Cytokines and monoclonal antibodies

  2007cites this paper
• Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.

  2005cites this paper